Loading...
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2: ERG into Prostate Cancer Prevention Trial Risk Calculator
BACKGROUND: The Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) is a commonly used risk tool for predicting the outcome on biopsy based on the established risk factors. OBJECTIVE: To determine whether incorporation of the novel urinary markers prostate cancer antigen 3 (PCA3) and TMPRSS2:E...
Na minha lista:
| Udgivet i: | Eur Urol Focus |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6077104/ https://ncbi.nlm.nih.gov/pubmed/29422418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euf.2018.01.010 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|